The next
generation
of nature.
generation
of nature.
Safe, pure, sustainable ingredients for life
Why Willow
Nature's benefits, for everyone
We believe in challenging conventional methods to bring the benefits of nature to everyone. Your customers and your industry demand the safest, most pure active pharmaceutical ingredients (APIs) available. Few can deliver. We can. Beginning with Cannabidol (CBD) and other cannabinoids, our leading biotechnology platform allows us to deliver consistent, economical, sustainable ingredients at a global scale.
01 Plant Biotech
Nature’s instructions for producing cannabinoids are encoded in the cannabis plant’s genome. We follow nature’s lead by identifying the genes responsible for cannabinoid production in cannabis.
Our Platform
Higher purity, lower cost
Plants are the best scientists. Using the instructions contained in the genes of therapeutic plants, we can produce the same compounds at higher purity, speed, consistency, and cost-effectiveness, but smaller environmental impact than traditional agriculture practices.
Our innovative research platform reinvents the production of active pharmaceutical ingredient (API) supplies for global pharmaceutical, health and wellness, and consumer packaged goods industries. Our current focus is on the production of pure CBD, with plans to target many more plant-sourced drugs in the future.
Products
Molecules that matter
Pure CBD
Our production technology will produce pure CBD that is sustainable, cost effective and scalable – supplying pharmaceuticals, beverages, topical creams, cosmetics, and other consumer packaged goods manufacturers with the quality product they demand.
- Ultra-pure
- Sustainable
- Large quantities
- Contaminant free
Beyond CBD
Our production technologies can be easily adapted to produce rare and minor cannabinoids, opioids, and more. Our platform makes access to these molecules possible at quantities unattainable through traditional plant extraction. Subscribe below for updates.
Get updates about cannabinoid availability, molecule discovery, and Willow Biosciences news.
About Us
Innovation in our DNA
Not everyone can do what we do. We are an elite team of scientists and business leaders pioneering how synthetic biology can bring the best of nature’s ingredients to market.
- Our team
- Our Partners
Management Team
Trevor Peters
President and Chief Executive Officer and Director
Mr. Peters is an experienced executive having co-founded four start-up companies in the past 15 years. Mr. Peters has raised over $1.0 billion in...
Travis Doupe
Chief Financial Officer
Mr. Doupe has over 18 years’ experience in financial leadership roles, principally in the international oil and gas industry, during which time he...
Dr. Chris Savile
Chief Operations Officer
Dr. Savile has 13 years’ experience in science, business development, and commercial operations roles in biotech. He is a highly experienced chemist,...
Jerry Ericsson
Vice President, Operations
Mr. Ericsson is an experienced clean-tech executive responsible for raising more than $20.0 million to commercialize thermochemical technologies for...
Dr. Mathias Schuetz
Vice President, Research and Development
Dr. Schuetz is an Adjunct Professor in the Department of Botany at the University of British Columbia, and a researcher and plant molecular biologist...
Board of Directors
Dr. Peter Seufer-Wasserthal
Chairman
Dr. Seufer-Wasserthal has more than 25 years’ experience in the technology and biotechnology sector. Dr. Seufer-Wasserthal is currently Chief...
Al Foreman
Director
Mr. Foreman has over 20 years of professional experience in private equity, corporate finance, and financial technology. Mr. Foreman is currently a...
Sadiq H. Lalani
Director
Mr. Lalani has been Chief Financial Officer of Kelt Exploration Ltd. since October 2012 and Vice President since October 2017. Before that, Mr. Lalani...
Donald Archibald
Director
Mr. Archibald is an independent businessman and the Executive Chairman of Cequence Energy Ltd. Mr. Archibald was a former director and audit committee...
Dr. Fotis Kalantzis
Director
Dr. Kalantzis has been co-founder of several public companies and has over 25 years’ experience in oil and gas exploration and development in...
Strategically located facilities
We currently have three facilities with over thirty science and technical staff in close proximity to allied university research and biotechnology hubs.
Please direct inquiries to our head office in Calgary, AB
Phone +1 403-910-5140
Email info@willowbio.com
3655 36th Street NW
Calgary, AB Canada T2L 1Y8
Strategically located facilities
We currently have three facilities with over thirty science and technical staff in close proximity to allied university research and biotechnology hubs.
Please direct inquiries to our head office in Calgary, AB
Email info@willowbio.com
3655 36th Street NW
Calgary, AB Canada T2L 1Y8
Careers
We are game-changers and rule breakers. We shake things up, we discover, we create, we push boundaries and we deliver, always.
Investors
Invest in Willow
Based in Calgary, Alberta, Willow Biosciences is a biotechnology company focused on revolutionizing industrial manufacturing of active pharmaceutical ingredients and other high value products that have traditionally been derived from plants.
Current WLLW stock price
data currently unavailable
Press releases
All SEDAR fillingsAnalyst Coverage
David Kideckel, PhD MBA
AltaCorp Capital Inc.
+1 647-776-8240
dkideckel@Altacorpcapital.com
Ammar Shah
Eight Capital
+1 647-426-1665
ashah@viiicapital.com
News